Bradycor SB-238592 bradykinin antagonist: Phase II trial

Cortech Inc. (CRTQ), Denver, Colo.
Product: Bradycor SB-238592 bradykinin

Read the full 92 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE